4-Star Stocks Poised to Pop: CVS Caremark (CVS)

4-Star Stocks Poised to Pop: CVS Caremark

Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, drugstore and pharmacy benefits giant CVS Caremark (NYSE: CVS ) has earned a respected four-star ranking.

With that in mind, let's take a closer look at CVS Caremark's business and see what CAPS investors are saying about the stock right now.

CVS facts

Headquarters (Founded)	Woonsocket, R.I. (1892)
Market Cap	$56.0 billion
Industry	Drug retail
Trailing-12-Month Revenue	$104.0 billion
Management	CEO Larry Merlo (since 2011) CFO David Denton (since 2010)
Return on Equity (Average, Past 3 Years)	9.7%
Cash/Debt	$1.7 billion / $10.8 billion
Dividend Yield	1.5%
Competitors	Rite Aid Walgreen Wal-Mart

Sources: S&P Capital IQ and Motley Fool CAPS.

On CAPS, 96% of the 1,688 members who have rated CVS believe the stock will outperform the S&P 500 going forward.

Last year, one of those bulls, DeeFool33, tapped CVS as a particularly clear opportunity:

I'm a fan of Peter Lynch's "buy what you know" and I am IN these stores all the time. CVS is always busy -- and I mean always at the many locations I frequent in [Massachusetts]. Rite-Aid, well, I rarely see more than 6 cars in the parking lot, ever. CVS is targeting its customer base with coupons, incentives all the time. They are always trying to attract business. Walgreens -- not sure where that it heading -- seems middle of the road to me right now.

If you want to retire rich, you need to put together the best portfolio you can. Owning exceptional stocks is a surefire way to secure your financial future. Of course, despite a strong four-star rating, CVS may not be your top choice.

We've found another retailer we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2012." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.

Want to see how well (or not so well) the stocks in this series are performing? Follow the new TrackPoisedTo CAPS account.

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Fool contributor Brian Pacampara owns no position in any of the companies mentioned. Try any of our Foolish newsletter services free for 30 days.

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Fool's disclosure policy always gets a perfect score.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.